Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 18INDUSTRY 4NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 21Lymphoma 10Lymphoma, Mantle-Cell 4Waldenstrom Macroglobulinemia 2Recurrence 2Mesothelioma, Malignant 2Lymphoma, Follicular 2Stomach Neoplasms 1Sezary Syndrome 1Rectal Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Immunoglobulin Light-chain Amyloidosis 1Hematologic Neoplasms 1Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Melphalan 5Dexamethasone 4Peripheral Blood Stem Cell Transplantation 3Filgrastim 3isatuximab 2Cyclophosphamide 2Calcium Dobesilate 2pomalidomide 1liposomal amphotericin B 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1belantamab mafodotin 1auricularum 1Watchful Waiting 1Thalidomide 1Stem Cell Transplantation 1Specimen Handling 1Moxifloxacin 1Morphine 1Magnetic Resonance Spectroscopy 1Interferon-alpha 1In Situ Hybridization, Fluorescence 1Dextromethorphan 1Cytogenetic Analysis 1Ciprofloxacin 1Caspofungin 1Bortezomib 1Biopsy 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Immunoglobulin Light-chain Amyloidosis × Bortezomib × Clear all
NCT06022939 2026-05-06

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

SWOG Cancer Research Network

Phase 3 Recruiting
338 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡